CLINICAL_TRIALS
trial_result
· 2013-11-01
Clinical Trial Update: Evaluation of Dapagliflozin Taken Twice-daily [Phase 3]
Summary
A Phase 3 trial evaluated twice-daily dapagliflozin for Type 2 diabetes; results were posted in November 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2013-11-01